Cadherin 1 negatively regulates SARS-CoV-2 infection in the olfactory epithelium.

Cadherin 1 negatively regulates SARS-CoV-2 infection in the olfactory epithelium.

Publication date: Aug 03, 2026

Olfactory dysfunction is a major symptom of COVID-19 syndrome. The critical genes contributing to SARS-CoV-2 infection are not fully understood. Here, we identified Cadherin 1 (CDH1), a hub in the interaction network of viral entry-related genes in human and mouse olfactory epithelium (OE), is coexpressed with ACE2 in sustentacular cells. CDH1 overexpression attenuates pseudoviral and authentic SARS-CoV-2 infection in ACE2-expressing HEK293T cells and human OE organoids, whereas CDH1 downregulation promotes infection. Mechanistically, CDH1 interacts with ACE2 and competes with the Spike protein for ACE2 binding. Three residues in CDH1 (W59, N168, and Q197) are critical for CDH1-ACE2 binding, and mutations at these residues weaken the interaction and enhance pseudoviral infection. In the OE of deceased COVID-19 patients, cells with higher viral load exhibit lower CDH1 expression. This inverse correlation between CDH1 expression and SARS-CoV-2 load is validated in human bronchial epithelial cells, and in lung ciliated and secretory cells. Collectively, our findings establish CDH1 as a novel restriction factor for SARS-CoV-2 infection in the olfactory system, potentially offering a target for antiviral therapy.

Open Access PDF

Concepts Keywords
Antiviral Ace2
Competes Binding
Proteins Cadherin
Therapy Cdh1
Viral Cells
Cov
Covid
Critical
Epithelium
Infection
Interaction
Olfactory
Pseudoviral
Sars
Viral

Semantics

Type Source Name
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH syndrome
drug DRUGBANK Huperzine B
disease MESH infection
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH anosmia
drug DRUGBANK Angiotensin II
drug DRUGBANK Serine
disease MESH olfactory impairment
pathway KEGG Viral replication
disease MESH inflammation
disease MESH death
drug DRUGBANK Dextrose unspecified form
disease MESH viral infection
disease MESH strain
drug DRUGBANK Proline
disease MESH MALS
drug DRUGBANK Trypsin
pathway REACTOME Digestion
pathway REACTOME Cilium Assembly
disease MESH tumor
pathway KEGG Tight junction
disease MESH PBS
drug DRUGBANK Trehalose
drug DRUGBANK Tromethamine
drug DRUGBANK Edetic Acid
drug DRUGBANK Glycerin
drug DRUGBANK Glycine
disease MESH asthma
pathway KEGG Asthma
drug DRUGBANK Fluorescein
disease MESH APC
disease MESH ECD
drug DRUGBANK Coenzyme M
disease MESH TCS
drug DRUGBANK Water
disease MESH PCs
disease MESH pku
drug DRUGBANK Esomeprazole
disease MESH AOI
drug DRUGBANK Flunarizine
drug DRUGBANK Sucrose
drug DRUGBANK Medical air
drug DRUGBANK Ketamine
drug DRUGBANK Xylazine
disease MESH body weight
drug DRUGBANK Human Serum Albumin
disease MESH included
drug DRUGBANK Gelatin
disease MESH Rp3
disease MESH FBS
disease MESH MCS
drug DRUGBANK Puromycin
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Sodium lauryl sulfate
disease MESH SDS
disease MESH hpi
disease MESH CAA
drug DRUGBANK Formic Acid
pathway REACTOME Release
drug DRUGBANK L-Cysteine
drug DRUGBANK Methionine
pathway REACTOME Acetylation
drug DRUGBANK L-Alanine
drug DRUGBANK Amino acids
drug DRUGBANK Phosphate ion
drug DRUGBANK Ampicillin
drug DRUGBANK Iodixanol
disease MESH Rad
drug DRUGBANK R411
disease MESH image
drug DRUGBANK Albendazole
drug DRUGBANK Diflunisal
disease MESH Hypoxia
pathway REACTOME Metabolism
disease MESH acc
disease MESH Taste Disorders
disease MESH Coronavirus Infection
disease MESH Dis
pathway REACTOME Autophagy
disease MESH gastric cancer
pathway KEGG Gastric cancer
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Guanosine
disease MESH colitis
disease MESH tumorigenesis
disease MESH ganglion
disease MESH ocular hypertension
disease MESH pneumonia
drug DRUGBANK Etoperidone
pathway REACTOME Reproduction

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *